The FDA has approved Lilly's Zepbound, a glp-1 agonist, for the treatment of sleep apnea, which affects 25 million Americans and is often treated with a CPAP machine, but is often declined due to its ...
“Today’s approval marks the first drug treatment option for certain patients with obstructive sleep apnea,” said Sally Seymour, M.D., director of the Division of Pulmonology, Allergy, and Critical ...
A new quick-and-easy nasal swab test for kids can diagnose the specific immune system drivers behind their asthma, ...
The obesity medication Zepbound can be used on-label to treat obstructive sleep apnea in adults with obesity, the FDA ...
Cases of a bacterial infection called "rabbit fever" have been increasing during the past decade, according to the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback